Shire’s chief steps down
October 21, 2003Shire's chief executive Rolf Stahel is to stand down after reports of a widening rift with US non-executive directors and …
Elan running $1bn loss
October 21, 2003Elan reported a net loss of $1 billion for the third quarter, following charges of $943 million.A significant portion of …
Bayer healthcare chief quits
October 21, 2003The head of Bayer's healthcare unit, Frank Morich, has resigned as troubles at the German company continue.Bayer is cutting back …
Medicines Partnership would involve industry
October 21, 2003The Medicines Partnership, a Department of Health scheme that promotes patient compliance, would lend its support to pharmaceutical industry projects. The …
Pharma faces outcome of EU balancing act
October 21, 2003Negotiations on the future of the European pharmaceutical industry have stepped up a gear after a crucial vote in the …
Pharma websites not defending company reputation
October 21, 2003Few companies within the UK sector communicate properly via the Internet, according to a new report that found key messages …
Claritin sales slump ahead of OTC switch
October 21, 2003Profits at Schering-Plough have been hit by the company's search for a follow-up to its blockbuster allergy drug Claritin.The combined …
Health authorities blocking change, say PCTs
October 21, 2003Strategic health authorities are too far removed from PCTs to help them innovate as they work on their plans for …
New lines of communication
October 21, 2003Medical Communications, Sales and Marketing MHRA, disease awareness campaigns
New guidelines from the Medicines and Healthcare Products Regulatory Agency (MHRA) have placed disease awareness campaigns under the spotlight.They spell …
Are you making the most of your web investment?
October 21, 2003Medical Communications digi pharma, investment, websites
Pharmaceutical companies have spent millions of pounds on websites since the mid-1990s. Although almost no one is prepared to admit …
Industry careers for pharmacoeconomists
October 21, 2003Business Services careers, pharmacoeconomists, recruitment
The last five years have seen a shift in pharmacoeconomics to the centre of corporate concerns. Pharmacoeconomics used to be …
Translating NHS reform into healthy profits
October 21, 2003Sales and Marketing NHS, healthcare, reform
Mind the gap
October 20, 2003Sales and Marketing NHS, healthcare, industry relations
There is a disconnection between what primary care organisation influencers want from a relationship with the pharma industry, and what …
Bringing new drugs to market…at last!
October 20, 2003Sales and Marketing product launch
In 1987 the average cost of development for new pharmaceutical products was $231 million, and it took between 10 and …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
